Bluelinea SA Cash Flow Conversion Efficiency

Latest as of June 2025: -0.615x

Bluelinea SA cash flow conversion efficiency. Based on the latest financial reports, Bluelinea SA (ALBLU) has a cash flow conversion efficiency ratio of -0.615x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-434.85K ≈ $-508.39K USD) by net assets (€706.70K ≈ $826.20K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Bluelinea SA (2009–2024)

Cash flow conversion efficiency of Bluelinea SA from 2009 to 2024. This chart illustrates how Bluelinea SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Bluelinea SA stock quote for real-time trading data and today's change.

Bluelinea SA Cash Flow Conversion Ratio Explained

Bluelinea SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Bluelinea SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bluelinea SA ranked by their cash flow conversion efficiency. Also see market cap of Bluelinea SA for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Xaar plc LSE:XAR	-0.059x
Falcon Gold Corp V:FG	0.003x
Ellen AB (publ) ST:ELN	-0.130x
Yida China Holdings Ltd STU:YC2	N/A
Asia Pacific Investama Tbk PT JK:MYTX	0.009x
INFINITII AI INC. F:Y31	0.085x
Kanger International Bhd KLSE:0170	-0.041x
Urban-Gro Inc NASDAQ:UGRO	0.056x

Annual Cash Flow Conversion Efficiency for Bluelinea SA (2009–2024)

The table below shows the annual cash flow conversion efficiency of Bluelinea SA from 2009 to 2024. Review Bluelinea SA (ALBLU) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€1.41 Million ≈ $1.65 Million	€857.90K ≈ $1.00 Million	0.607x	+352.87%
2023-12-31	€2.68 Million ≈ $3.14 Million	€-644.38K ≈ $-753.35K	-0.240x	-2.49%
2022-12-31	€4.30 Million ≈ $5.03 Million	€-1.01 Million ≈ $-1.18 Million	-0.234x	-176.82%
2021-12-31	€-1.85 Million ≈ $-2.17 Million	€-565.52K ≈ $-661.15K	0.305x	+111.34%
2020-12-31	€886.46K ≈ $1.04 Million	€-2.39 Million ≈ $-2.79 Million	-2.691x	-2997.46%
2019-12-31	€2.27 Million ≈ $2.65 Million	€-196.87K ≈ $-230.16K	-0.087x	+41.82%
2018-12-31	€5.05 Million ≈ $5.91 Million	€-754.86K ≈ $-882.51K	-0.149x	+99.37%
2017-12-31	€6.35K ≈ $7.42K	€-149.58K ≈ $-174.88K	-23.557x	+90.18%
2016-12-31	€9.34K ≈ $10.92K	€-2.24 Million ≈ $-2.62 Million	-239.813x	-167621.39%
2015-12-31	€7.45K ≈ $8.71K	€-1.07K ≈ $-1.25K	-0.143x	+75.05%
2014-12-31	€2.92 Million ≈ $3.41 Million	€-1.67 Million ≈ $-1.96 Million	-0.573x	-30.80%
2013-12-31	€1.96 Million ≈ $2.29 Million	€-856.72K ≈ $-1.00 Million	-0.438x	-61.22%
2012-12-31	€2.22 Million ≈ $2.59 Million	€-602.23K ≈ $-704.07K	-0.272x	-51.44%
2009-12-31	€-367.77K ≈ $-429.97K	€66.00K ≈ $77.16K	-0.179x	--

About Bluelinea SA

PA:ALBLU France Medical Devices

Market Cap

$1.29 Million

€1.10 Million EUR

Market Cap Rank

#30473 Global

#563 in France

Share Price

€0.06

Change (1 day)

+0.00%

52-Week Range

€0.05 - €0.52

All Time High

€6.30